Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis).
Author / Organization: Potestio L, Corrao S, Mastorino L, Gaiani FM, Cozzani EC, Maurelli M, Tommasino N, Caccavale S, Gargiulo L, Carrera CG, Sacchelli L, Longo C, Marchetti S, Michelucci A, Valguarnera D, Carugno A, Mozzato S, Lussana F, Mercadante L, Cangialosi L, Messina F, Di Brizzi EV, Bianco M, Scibetta S, Assorgi C, Campoli M, Angileri RG, Dattola A, Trovato E, Esposito M, Zerbinati N, Guarneri C, Loconsole F, Dini V, Campanati A, Lasagni C, Bardazzi F, Marzano AV, Travaglini M, Narcisi A, Balato A, Megna M, Girolomoni G, Burlando M, Malagoli P, Ribero S, Orsini D
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2026 |
| Source Host |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.